G

Gain Therapeutics

35 employees

Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.

Basic info

Industry

biotechnology research

Sectors

Rare diseases
Biotechnology
neurodegenerative diseases
Health Care
lysosomal storage disorders
Therapeutics
pharmacological chaperones
Pharmaceutical
oncology

Date founded

2017

Funding rounds raised

Total raised

$2.8M

from 4 investors over 4 rounds

G

Gain Therapeutics raised undisclosed on April 28, 2023

Investors: Innosuisse - Schweizerische Agentur für Innovationsförderung

G

Gain Therapeutics raised $1.6M on July 23, 2019

Investors: Innosuisse - Schweizerische Agentur für Innovationsförderung

G

Gain Therapeutics raised $2.8M on February 19, 2019

Investors: 3B Future Health Fund and Tiventures SA

FAQ